secwatch.observer — SEC 8-K summary
======================================

Issuer:     BICYCLE THERAPEUTICS PLC (BCYC)
CIK:        0001761612
Form:       8-K
Filed at:   2026-06-18T12:21:16+00:00
Accession:  0001104659-26-075451
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Bicycle Therapeutics shareholders approve all proposals at 2026 AGM
-------------------------------------------------------------------

- 98.64% of shares represented; all 9 proposals passed with large majorities.
- Felix Baker re-elected with 46.2M for vs 3.4M against; Hervé Hoppenot re-elected with 49.3M for.
- Advisory vote on executive compensation passed: 48.7M for, 0.8M against.
- Ratification of PwC as auditor for FY2026 passed: 49.4M for, 0.2M against.
- Directors' remuneration policy approved: 48.2M for, 1.3M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1761612/000110465926075451/0001104659-26-075451-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1761612/000110465926075451/tm2618222d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-075451

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer